Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
CNS Drugs|October 7, 2024
Long-Term (12-Month) Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine: Data from the Phase 3 Open-Label ASCEND StudyStewart J Tepper, Detlef Albrecht, Jessica Ailani, et al.British Journal of Clinical Pharmacology|October 22, 2004
Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral dosesChukwuemeka S Okereke, Louis Kirby, Dinesh Kumar, et al.Pain|December 13, 2006
Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studiesAaron I Vinik, Michael Tuchman, Beth Safirstein, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 3, 2005
A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairmentLeon J Thal, Steven H Ferris, Louis Kirby, et al.Journal of Clinical Pharmacology|June 4, 2009
Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's diseaseCarol Addy, Chris Assaid, David Hreniuk, et al.Pageof 1